CLX
Fiscal year ends June Quarters are offset from the calendar — Q1 is Jul–Sep

The Clorox Company is a multinational manufacturer and marketer of consumer and professional products. The company operates through four reportable segments: Health and Wellness, Household, Lifestyle, and International. Its portfolio includes cleaning and disinfecting products under the Clorox, Pine-Sol, and Liquid-Plumr brands; skin sanitization products under Purell and GOJO; professional hygiene solutions under CloroxPro and Clorox Healthcare; and food service products under Hidden Valley. The Household segment features bags and wraps under Glad, cat litter under Fresh Step and Scoop Away, and grilling products under Kingsford. The Lifestyle segment comprises food products under Hidden Valley, water-filtration systems under Brita, and natural personal care items under Burt’s Bees. The company sells its products primarily through mass retailers, grocery outlets, warehouse clubs, and e-commerce channels. It serves both consumer and professional customers, including healthcare and institutional markets. Founded in 1913, the company completed the acquisition of GOJO in April 2026, integrating the Purell brand and expanding its presence in business-to-business health and hygiene solutions.

Summarised from the company's own disclosures, fiscal year ended Aug 2026

Industry Household & Personal Products Homepage thecloroxcompany.com
Sector Consumer Defensive IR page investors.thecloroxcompany.com/overview/default.aspx
Tags
cleaning products, disinfectants, sanitizers, cat litter, grilling products, water filtration, personal care, food dressings, professional hygiene, consumer brands, Clorox, Pine-Sol, Liquid-Plumr, Poett, Glad, Fresh Step, Kingsford, Hidden Valley, Brita, Burt’s Bees, Purell, CloroxPro, Clorox Healthcare, GOJO, Scoop Away, Clorox2, Scentiva, Tilex, Formula 409
Press page thecloroxcompany.com/news/press-releases

Metrics

Valuation  
Market cap $ 12.101B
Market cap (USD) $ 12.101B
P/E 15.35
PEG 0.75
P/BV -310.29
P/S 1.70
P/OCF 12.34
P/FCF 15.90
Dividend yield 4.9%
Turnover / mcap —
Returns  
ROE 249.6%
ROI 28.9%
ROIC 32.1%
Profit margin 11.4%
Growth  
Revenue growing No
Profits growing Yes
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) 20.6%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 17
Quality score 31.6%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009
Revenue 7.104B 7.093B 7.389B 7.107B 7.341B 6.721B 6.214B 6.124B 5.973B 5.761B 5.655B 5.591B 5.623B 5.468B 5.231B 5.534B 5.45B
Net profit 810M 280M 149M 462M 710M 939M 820M 823M 701M 648M 580M 558M 572M 541M 557M 603M 537M
Free cash flow 761M 483M 930M 535M 945M 1.292B 786M 780M 637M 606M 749M 629M 581M 420M 470M 616M 541M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009
Share price 120.07 136.47 159.04 140.98 179.91 219.37 153.11 135.25 133.24 138.39 104.02 91.4 83.14 72.46 67.44 62.16 55.84
Price performance 12m -0.12 -0.14 0.13 -0.22 -0.18 0.43 0.13 0.02 -0.04 0.33 0.14 0.1 0.15 0.07 0.08 0.11 0.07

Filed figures

Figure Jun 2017 Jun 2018 Jun 2019 Jun 2020 Jun 2021 Jun 2022 Jun 2023 Jun 2024 Jun 2025 Jun 2026
Balance sheet detail
Trade receivables (USD) 565M 600M 631M 648M 604M 681M 688M 695M 821M 791M
↳ YoY growth -0.7% +6.2% +5.2% +2.7% -6.8% +12.7% +1.0% +1.0% +18.1% -3.7%
↳ 5y CAGR -0.4% +0.7% +2.9% +4.5% +1.2% +3.8% +2.8% +2.0% +4.8% +5.5%
Borrowings, current (USD) 804M 199M 396M 0.00 300M 237M 50M 4M 4M 1.09B
Borrowings, non-current (USD) 1.39B 2.28B 2.29B 2.78B 2.48B 2.47B 2.48B 2.48B 2.48B 3.98B
Lease liabilities (USD) — — — 356M 402M 411M 427M 452M 428M 530M
Cash and deposits (USD) 418M 131M 111M 871M 319M 183M 367M 202M 167M 143M
Intangible assets (USD) 722M 929M 912M 894M 918M 884M 712M 681M 566M —
Right-of-use assets (USD) — — — 291M 332M 342M 346M 360M 333M 401M
Net debt (borrowings + leases - cash) (USD) 1.78B 2.35B 2.57B 2.27B 2.87B 2.94B 2.59B 2.74B 2.75B 5.46B
Cash flow detail
Operating cash flow (USD) 868M 974M 992M 1.55B 1.28B 786M 1.16B 695M 981M 612M
Purchases of property, plant and equipment (USD) -231M -194M -206M -254M -331M -251M -228M -212M -220M -207M
Change in receivables (cash effect) (USD) -1M -24M -32M -27M 82M -84M -13M -34M -145M 151M
Change in inventories (cash effect) (USD) -19M -21M -7M 50M -282M -18M 58M 55M 63M -71M
Change in payables (cash effect) (USD) -34M -47M 17M 291M 311M -47M 157M -140M -124M 38M
Dividends paid (cash effect) (USD) -412M -450M -490M -533M -558M -571M -583M -595M -602M -602M
Share buybacks (cash effect) (USD) -183M -271M -661M -248M -905M -25M 0.00 0.00 -332M -256M
Interest paid (cash effect) (USD) -78M -75M -87M -89M -89M -89M -99M -102M -97M -122M
Income taxes paid (cash effect) (USD) -347M -245M -207M -241M -303M -100M -73M -347M -264M -104M
Share-based compensation (USD) 51M 53M 43M 50M 50M 52M 73M 74M 81M 48M
Operating cash flow before change in receivables (USD) 869M 998M 1.02B 1.57B 1.19B 870M 1.17B 729M 1.13B 461M
Free cash flow (OCF - PPE - intangibles) (USD) 637M 780M 786M 1.29B 945M 535M 930M 483M 761M 405M
Income detail
Research and development expense (USD) 135M 132M 136M 145M 149M 132M 138M 126M 121M 116M
↳ 5y CAGR +2.2% +0.3% +1.7% +1.3% +1.1% -0.4% +0.9% -1.5% -3.6% -4.9%
Total comprehensive income (USD) 728M 819M 804M 901M 813M 538M 147M 630M 822M 601M
Comprehensive income to owners (USD) 728M 819M 804M 901M 804M 529M 135M 618M 808M 587M
Provision for credit losses (USD) 3M — — — — — — — — —
Credit cost ratio (credit losses / average receivables) (%) 0.5% — — — — — — — — —
Reported Aug 15, 2017 Aug 14, 2018 Aug 14, 2019 Aug 13, 2020 Aug 10, 2021 Aug 10, 2022 Aug 10, 2023 Aug 8, 2024 Aug 8, 2025 Aug 7, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

11/04/2026

Cat parents can shop designer-inspired scents No. 9 and No. 27, each with 30 days of odor control, exclusively at Walmart.com starting Nov. 4, 2026.

OAKLAND, Calif., Nov. 4, 2026 /PRNewswire/ -- Fresh Step, the premium cat litter brand  and decades-long leader in odor control, is bringing a touch of everyday luxury to the litter box with new Fresh Step Fleur de Purr: a clumping clay litter featuring two designer-inspired fragrances: No. 9 and No. 27. The formula delivers 30 days of odor control and is available exclusively at Walmart.com  beginning today, with Walmart stores to follow Dec. 26.

Fleur De Purr

What Makes Fleur de Purr Different?
Fresh Step Fleur de Purr pairs the odor control performance cat parents expect from Fresh Step with an unexpected upgrade: fine-fragrance-inspired scents designed specifically for the litter box. Available in No. 9 and No. 27, the lightly scented, clumping litter delivers 30 days of odor control when used as directed. Think fine fragrance, made for the litter box.

"Cat parents put thought into making their homes feel and smell luxurious, and the litter box shouldn't be the exception," said Deb Crandall, Marketing & Innovation Lead for Fresh Step. "Fleur de Purr combines the odor control people expect from Fresh Step with designer-inspired fragrances developed with cat safety in mind, making an everyday cat-care essential feel anything but basic."

What Are the Key Features of Fresh Step Fleur de Purr?

  • Two designer-inspired scents: No. 9 and No. 27
  • 30 days of odor control when used as directed
  • Four times more odor-eliminating activated carbon, vs. Fresh Step Odor Shield
  • Black carbon odor-shield granules with multi-layer odor-lock technology
  • Helps fight ammonia odors before they start
  • Fresh Step's paw-activated fragrance technology with Febreze freshness
  • Low-dust formula that forms tight clumps for easy scooping
  • Compatible with automatic litter boxes

How Does Fleur de Purr Control Odor?
Fleur de Purr is designed to help neutralize litter box odors at the source rather than relying on fragrance alone to cover them up. Black carbon odor-shield granules with multi-layer odor-lock technology absorb odor molecules and help fight fecal, urine and bacterial odors on litter. The formula is supercharged with four times more odor-eliminating activated carbon than Fresh Step Odor Shield, helps fight ammonia odors before they start, and provides 30 days of odor control when used as directed.

How Does Paw-Activated Fragrance Technology Work?
Fleur de Purr features Fresh Step's paw-activated fragrance technology, which protects each scent inside tiny, starch-based capsules within the litter. Moisture and movement from a cat stepping, scratching or pawing help release freshness and subtle fragrance during litter box use.

**How Can Cat Parents Choose Between the Two Fleur de Purr Scents?
**Both scents deliver the same Fresh Step odor control performance and safety standards, but offer different fragrance profiles:

  • Fleur de Purr No. 9: Inspired by the viral santal obsession. Opens with silken soft woods, gives way to sheer violet leaf and settles into warm cardamom. A woody, refined, sandalwood-inspired fragrance with a modern, sophisticated feel.
  • Fleur de Purr No. 27: Brazilian sunshine in a box. Layers golden amber with cozy cashmere and soft florals before settling into a musky, sun-warmed finish, for those who prefer warm, amber-forward fragrances.

Where Can I Buy Fresh Step Fleur de Purr, and How Much Does It Cost?
Fresh Step Fleur de Purr No. 9 and No. 27 come in a 20 lb. carton with an MSRP of $20 and are available on Walmart.com  beginning Nov. 4, 2026, and in Walmart stores beginning Dec. 26, 2026. Fleur de Purr will be available nationally in April 2027.

How fragrant is Fresh Step Fleur de Purr?
Fleur de Purr is lightly scented, offering nuanced, distinctive notes via paw-activated fragrance technology, which helps release freshness as a cat uses the litter box.

Is Fresh Step Fleur de Purr low dust?
Yes. Fleur de Purr is a low-dust clumping clay litter that forms tight clumps for easy scooping.

Does Fresh Step Fleur de Purr work in automatic litter boxes?
Yes. Fleur de Purr is compatible with automatic litter boxes.

**Is Fresh Step Fleur de Purr safe for cats?
**All Fresh Step products undergo a rigorous safety assessment, including toxicologist review to help ensure the product is safe for you and your cat. Fresh Step partners with leading fragrance houses to create modern fragrance experiences designed with cats and their people in mind. Every fragrance undergoes a safety assessment, and follows globally recognized International Fragrance Association (IFRA) standards informed by Research Institute for Fragrance Materials (RIFM) science.

Learn More
For more on Fleur de Purr and the full Fresh Step lineup, visit FreshStep.com . Shop Fleur de Purr No. 9 and No. 27 exclusively on Walmart.com .

**About Fresh Step
**Fresh Step® is a premium cat litter brand built around one simple idea: when your home feels fresh, there's more room to enjoy life with your cat. With trusted odor-control technology and litter solutions designed for the needs of cats and their people, Fresh Step helps cat parents feel confident in their litter box every day. Fresh Step has also donated millions of dollars and tons of litter to more than 1,400 shelters, helping cats feel more comfortable while they wait for loving homes. Learn more at FreshStep.com .

logo

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/fresh-step-debuts-fleur-de-purr-bringing-fine-fragrance-inspired-luxury-to-the-litter-box-302928987.html

SOURCE Fresh Step

View All News

Media Contacts

Business/financial media inquiries:

[email protected]

Brand media inquiries:

Click here to view individual brand contacts

Investor inquiries:

[email protected]

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At The Clorox Company, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to The Clorox Company to send you the requested Investor Email Alert updates.

* Required

Investor Alert OptionsEmail Address *

Investor Alert Options *
News Quarterly Reports Annual Reports SEC Filings End of Day Stock Quote Events & Presentations

Submit Sign Up

Unsubscribe

Email Alert Sign Up Confirmation



Accessibility Statement

The Clorox Company is committed to making its website accessible for all users, and will continue to take steps necessary to ensure compliance with applicable laws.

If you have difficulty accessing any content, feature or functionality on our website or on our other electronic platforms, please call us at 1-800-227-1860 so that we can provide you access through an alternative method.


© 2024 The Clorox Company. All Rights Reserved.

The Clorox Company Family of Brands

(Opens in new window)

We use technology, such as cookies, to personalize and enhance your experience. By continuing to use this site, you agree to our use of cookies.Privacy Policy

Cookies Settings

Company Logo

Your Privacy

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to and to give you a more personalized web experience.

Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings.
Privacy Policy

Do Not Sell or Share for Targeted Advertising

Under some state laws you have the right to opt out of the selling or sharing of your information for cross-context behavioral advertising and/or certain types of targeted advertising (“behavioral advertising”).

To turn off the behavioral advertising cookies and trackers on this website, toggle “Targeting / Advertising Cookies” to “off” and click “Save Settings.” If the toggle is already set to “off” - you may have already updated your cookie settings, or the Global Privacy Control (“GPC”) signal may be enabled in your browser.

In most cases, your opt-out preference will be tracked via a cookie, which means your selection is limited to the specific device and browser you are using during this visit to our website. If you visit this website from a different device or browser, change your browser settings, or if you clear your cookies, you may need to opt out again.

If you would like to update other cookie-related preferences visit the "Cookie Settings" link in the footer of this webpage.

Additionally, you may have the right to obtain a list of specific third parties (as defined under applicable law) to which we may have disclosed personal information. That information can be found below.

Allow All

Manage Consent Preferences

Essential Cookies

Always Active

These cookies are necessary for the website to function properly and cannot be switched off in our systems. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work.

View Vendor Details

Performance / Analytics Cookies

Performance / Analytics Cookies

Among other things, these cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. If the website uses third party session replay software, these cookies allow us to monitor and analyze your activity on the website. If you do not allow these cookies we may not know when you have visited our site, and may not be able to monitor its performance. By disabling any type of cookie, you will disable most cookies other than the essential cookies.

View Vendor Details

Functional Cookies

Functional Cookies

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third party providers. If you do not allow these cookies then some or all of these services may not function properly. By disabling any type of cookie, you will disable most cookies other than the essential cookies.

View Vendor Details

Targeting / Advertising Cookies

Targeting / Advertising Cookies

These cookies may be set through our site by us or our advertising partners. They may be used to build a profile of your interests and show you relevant advertisements on other sites. By disabling any type of cookie, you will disable most cookies other than the essential cookies

View Vendor Details


Behavioral Advertising Linked To Your Email Address:

You may have previously provided your email address to us. In some cases, we may use email addresses or other non-cookie personal information to deliver behavioral advertising to consumers via third parties such as Amazon, Facebook, Google, Omnicom, and Walmart. To request that your personal information is not shared for these purposes, please enter your email address below:

Email:

Once you have made all of your elections, click “Save Settings” to save your settings and close the window.


Deletion, Access, Correction, or Portability Requests

If you are a U.S. consumer and would like to submit other privacy requests, please visit our U.S. Data Subject Request page.

11/02/2026

OAKLAND, Calif., Nov. 2, 2026 /PRNewswire/ -- The Clorox Company (NYSE: CLX) today reported results for the first quarter of fiscal year 2027, which ended Sept. 30, 2026.

"We entered this fiscal year focused on steadily improving performance while navigating continued input cost pressures. We made good progress in the first quarter, delivering better-than-expected results through strong execution and timing benefits," said Chair and CEO Linda Rendle. "The cost environment has become more challenging, with higher inflationary pressures reflected in our updated outlook. We have plans in place to mitigate these pressures while continuing to invest behind our brands. Importantly, we continue to make progress against our strategic priorities, including improving market share and integrating GOJO to unlock the full potential of Clorox Purell ProCare. We remain confident in the strength of our long-term trajectory and our ability to create sustainable value for shareholders."

First-Quarter Fiscal Year 2027 Summary

Following is a summary of key results for the first quarter. All comparisons are with the first quarter of fiscal year 2026 unless otherwise stated.

  • Net sales increased 33% to $1.91 billion. The impact of the GOJO acquisition was about 15 points. Organic sales1 increased 18%, reflecting the impact of lapping the ERP transition-related inventory drawdown in the year-ago quarter.

  • Gross margin decreased 130 basis points to 40.4% from 41.7% in the year-ago quarter, primarily driven by higher commodity costs and higher manufacturing and logistics costs, partially offset by higher volume and cost savings. The impact from inventory step-up of the GOJO acquisition was about 50 basis points.

  • Diluted net earnings per share (diluted EPS) increased 114% to $1.39 from $0.65 in the year-ago quarter. The increase includes the impact of lapping the company's investment in digital capabilities and productivity enhancements compared to the prior period, partially offset by GOJO transaction costs primarily related to integration costs and inventory step-up.

  • Adjusted EPS****1 increased 82% to $1.55 from $0.85 in the year-ago quarter, primarily driven by higher net sales, cost savings and a lower tax rate, partially offset by higher commodity costs and higher manufacturing and logistics costs. Adjusted EPS growth rate reflects the impact of lapping the ERP transition-related inventory drawdown in the year-ago quarter, which was about 90 cents.

  • Year-to-date net cash provided by operations was $143 million compared to $93 million in the year-ago period, representing a 54% increase.

This press release includes certain non-GAAP financial measures. See "Non-GAAP Financial Information" at the end of this press release for more details.

____________________________

1 Organic sales growth / (decrease) and adjusted EPS are non-GAAP measures. See Non-GAAP Financial Information at the end of this press release for reconciliations to the most comparable GAAP measures.

Strategic and Operational Highlights

The following are recent strategic and operational highlights:

  • Delivered one of the strongest quarters of cost savings on record, while continuing to advance productivity initiatives and capabilities that provide fuel to invest in growth and innovation.

  • Officially launched Clorox Purell ProCare , bringing together CloroxPro and GOJO with a unified sales and service organization and network of leading distributors that provide professional and healthcare customers convenient access to a broad portfolio of innovative solutions from trusted brands.

  • Continued to invest in consumer-inspired innovation across the portfolio, including Burt's Bees Hydrating Lip Balms and Lip Tints  in a new squeeze tube format, Purell Hand Sanitizer Sprays  in new scents, seasonal Glad, Pine-Sol and Clorox Scentiva offerings  and Hidden Valley Ranch Spooky Ranch , bringing consumers more variety and seasonal options from brands they know and trust.

  • Named one of the World's Most Trustworthy Companies by Newsweek  and recognized among America's Most Innovative Companies by both Forbes  and Business Insider  reflecting the company's continued focus on operating with integrity and creating superior experiences for consumers.

Key Segment Results

The following is a summary of key first-quarter results by reportable segment. All comparisons are with the first quarter of fiscal year 2026 unless otherwise stated.

Net sales increased 33%, driven by 31 points of higher volume and 2 points of favorable price mix. The impact of the GOJO acquisition was 15 points. First-quarter organic sales increased 18%, reflecting about 18 points of benefit from lapping the ERP transition-related inventory drawdown in the year-ago quarter.

Health and Wellness (Cleaning; Professional Products)

  • Net sales increased 62%, driven by 55 points of higher volume and 7 points of favorable price mix. The GOJO acquisition contributed approximately 39 points to net sales growth. Organic sales increased 23%, primarily driven by the impact of lapping the ERP transition-related inventory drawdown in the year-ago quarter.

  • Segment adjusted EBIT2 increased 69%, primarily due to higher net sales and cost savings, partially offset by higher manufacturing and logistics costs and higher commodity costs.

Household (Bags and Wraps; Cat Litter; Grilling)

  • Net sales increased 17%, driven by 17 points of higher volume. The volume increase was primarily driven by the impact of lapping the ERP transition-related inventory drawdown in the year-ago quarter.
  • Segment adjusted EBIT increased 11%, primarily due to higher net sales, partially offset by higher commodity and manufacturing and logistics costs.

Lifestyle (Food; Water Filtration; Natural Personal Care)

  • Net sales increased 16%, driven by 15 points of higher volume and 1 point of favorable price mix. The volume increase was primarily driven by the impact of lapping the ERP transition-related inventory drawdown in the year-ago quarter.
  • Segment adjusted EBIT increased 58%, primarily due to higher net sales, partially offset by higher commodity costs.

International (Sales Outside the U.S.)

  • Net sales increased 11%. Organic sales increased 9%, driven by 9 points of organic volume growth, supported by strong shipments across several regions, particularly in Latin America.

  • Segment adjusted EBIT increased 63%, primarily due to higher net sales and cost savings, partially offset by higher commodity costs.

____________________________

2 Adjusted EBIT is a non-GAAP measure. See Non-GAAP Financial Information at the end of this press release for reconciliations to the most comparable GAAP measures.

ERP Transition Impact

During the fourth quarter of fiscal year 2025, retailers placed orders in advance of the company's ERP system transition in the U.S. to minimize any potential inventory impacts during the implementation phase. The shipments of incremental inventory provided a benefit to fourth-quarter 2025 net sales. These shipments added about 3.5 points of sales and about 90 cents of earnings per share to fiscal year 2025.  

In fiscal year 2026, retailers drew down on this inventory during the company's ERP transition period, resulting in lower shipments. From a year-over-year sales growth perspective, the reduction in sales from this inventory drawdown translates to about 7.5 points of decline as compared to the higher base in fiscal year 2025. Similarly, this inventory drawdown reduced fiscal year 2026 earnings per share by about 90 cents. In comparison to the higher base in fiscal year 2025, this results in a year-over-year reduction of about 28% to fiscal year 2026 diluted earnings per share and about 23% to fiscal year 2026 adjusted earnings per share. 

In fiscal year 2027, the company will lap the above-described inventory drawdown, which is expected to result in more than 3.5 points of benefit to net sales growth. This lap is also expected to benefit the company's adjusted EPS growth.

Fiscal Year 2027 Outlook

The company is maintaining its sales and adjusted EPS outlook ranges. Based on the latest assumptions on input costs and acquisition synergies, the company updated its gross margin and selling and administrative expenses, and expects adjusted EPS results closer to the low end of the range.

  • Net sales are still expected to be up 13% to 14% compared to the prior year, including about 9.5 points of benefit from the GOJO acquisition. Organic sales are expected to increase about 3.5% to 4.5%, including more than 3.5 points of benefit from lapping the ERP-related drawdown in the prior fiscal year.

  • Gross margin is now expected to be about 41.5%, reflecting higher-than-normal inflationary headwinds and negative mix more than offsetting the benefits from cost savings and pricing actions. This includes about 20 basis points of negative impact primarily related to the GOJO inventory step-up.

  • Selling and administrative expenses are now expected to be about 15.5% of net sales. This includes about 40 basis points of negative impact from GOJO transaction-related costs.

  • Advertising and sales promotion spending is still expected to be about 10% of net sales. This assumes about 12% of net sales for its retail businesses.

  • The company's effective tax rate is still expected to be about 23%.

  • Diluted EPS is still expected to be between $5.41 and $5.71, a year-over-year increase of 12% to 19%, respectively. This includes about 29 cents of impact from transaction-related costs associated with the GOJO acquisition, which are expected to flow through cost of goods sold as well as selling and administrative expenses.

  • Adjusted EPS is still expected to be between $5.70 and $6.00, or an increase between 3% and 8%, respectively. These growth rates include the benefit of lapping the inventory drawdown related to the ERP transition in the prior year.

Net sales (percentage change versus the year ago period)
Fiscal year 2025 full year Fiscal year 2026 full year Fiscal year 2027 full year outlook
Impact Impact Low High
Net sales growth / (decrease) (GAAP) 0 % (5) % 13 % 14 %
Add/(Subtract): Divestitures/acquisitions 5 (3) (9.5) (9.5)
Organic sales growth / (decrease) (non-GAAP) 5 % (8) % 3.5 % 4.5 %
Note: Approximate impact from incremental shipments related to ERP transition 3.5 % (7.5) % >3.5% >3.5%
Diluted earnings per share
Fiscal year 2025 full year Fiscal year 2026 full year Fiscal year 2027 full year outlook
Impact Impact Low High
As estimated (GAAP) $           6.52 $           4.81 $           5.41 $           5.71
Loss on divestiture 0.94 — — —
Acquisition and integration costs — 0.36 0.29 0.29
Cyberattack costs, net of insurance recoveries (0.42) — — —
Digital capabilities and productivity enhancements investment 0.68 0.36 — —
As adjusted (non-GAAP) $           7.72 $           5.53 $           5.70 $           6.00
Note: Approximate impact from incremental shipments related to ERP transition $           0.90 $          (0.90) $              — $              —

Clorox Earnings Conference Call Schedule

At approximately 4:15 p.m. ET today, Clorox will post prepared management remarks regarding its first quarter fiscal year 2027 results.

At 5 p.m. ET today, the company will host a live Q&A audio webcast with Chair and CEO Linda Rendle and Chief Financial Officer Luc Bellet to discuss the results.

Links to the live (and archived) webcast, press release and prepared remarks can be found at Clorox Quarterly Results.

For More Detailed Financial Information 

Visit the company's Quarterly Results for the following: 

  • Supplemental unaudited volume and sales growth information 

  • Supplemental unaudited gross margin drivers information  

  • Supplemental unaudited cash flow information and free cash flow reconciliation 

  • Supplemental unaudited reconciliation of earnings before interest and taxes (EBIT) and adjusted EBIT

  • Supplemental unaudited reconciliation of adjusted earnings per share (EPS)

Note: Percentage and basis-point, or point, changes noted in this press release are calculated based on rounded numbers, except for per-share data and the effective tax rate.

About The Clorox Company

The Clorox Company (NYSE: CLX) champions people to be well and thrive every single day. Headquartered in Oakland, California since 1913, Clorox integrates sustainability into how it does business. Driven by consumer-centric innovation, the company is committed to delivering clearly superior experiences through its trusted brands, including Brita®, Burt's Bees®, Clorox®, Fresh Step®, Glad®, Hidden Valley®, Kingsford®, Liquid-Plumr®, PineSol® and Purell® as well as international brands such as Chux®, Clorinda® and Poett®. Visit thecloroxcompany.com to learn more.

CLX-F

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, among others, regarding the acquisition and integration of GOJO Industries, Inc. ("GOJO" and now operating as Clorox Purell ProCare), and any such forward-looking statements involve risks, assumptions and uncertainties. Except for historical information, statements about future volumes, sales, organic sales growth, foreign currencies, costs, cost savings, margins, earnings, earnings per share, including as a result of the company's strategic transactions, diluted earnings per share, foreign currency exchange rates, tax rates, cash flows, plans, objectives, expectations, growth or profitability are forward-looking statements based on management's estimates, beliefs, assumptions and projections. Words such as "could," "may," "expects," "anticipates," "targets," "goals," "projects," "intends," "plans," "believes," "seeks," "estimates," "will," "predicts," and variations on such words, and similar expressions that reflect the company's current views with respect to future events and operational, economic and financial performance are intended to identify such forward-looking statements. These forward-looking statements are only predictions, subject to risks and uncertainties, and actual results could differ materially from those discussed. Important factors that could affect performance and cause results to differ materially from management's expectations, are described in the sections entitled "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the company's Annual Report on Form 10-K for the fiscal year ended June 30, 2026, as updated from time to time in the company's Securities and Exchange Commission filings. These factors include, but are not limited to: the risks arising from the integration of the Clorox Purell ProCare business, including the ability to successfully integrate Clorox Purell ProCare's operations, systems, controls, culture, customers, suppliers and personnel, and to realize the anticipated benefits and synergies of the acquisition, including cost savings and growth opportunities, when expected or at all; the risks of adapting to Clorox Purell ProCare's business-to-business ("B2B") operating model, including differences in distribution channels, go-to-market strategies, margin profiles and customer requirements, increased exposure to customer concentration and consolidation among distributors, group purchasing organizations, health systems and other institutional customers in B2B channels, and potential channel conflict with the company's consumer business; the risk of increased regulatory exposure resulting from Clorox Purell ProCare's portfolio of products subject to U.S. Food and Drug Administration oversight, including products regulated as cosmetics and over-the-counter drugs; the risk of unexpected costs, expenses or litigation resulting from the GOJO acquisition; the risk of impairment charges related to intangible assets acquired in connection with the GOJO acquisition; the risks related to disruption of the company's ongoing business operations and diversion of management time and resources from the company's strategic transactions; the risk that the GOJO acquisition may have an adverse effect on the company's ability to retain key personnel, customers and suppliers; unfavorable general economic and geopolitical conditions beyond the company's control, including inflation, supply chain disruptions, labor shortages, wage pressures, fuel and energy costs, interest rate fluctuations, foreign currency exchange rate fluctuations, weather events or natural disasters, disease outbreaks or pandemics, terrorism, and unstable geopolitical conditions, including active armed conflicts and military hostilities in the Middle East, such as the ongoing conflict involving Iran, and rising tensions in various parts of the world, as well as macroeconomic and geopolitical volatility and uncertainty resulting from a number of these and other factors, such as actual and potential shifts in U.S. and foreign trade policies and agreements, escalating trade tensions between the U.S. and its trading partners, especially China, the potential expansion of sanctions regimes, and disruptions to global markets or transportation routes, particularly due to the imposition of U.S. and retaliatory tariffs; the impact of market and category declines, and the company's product and geographic mix on its ability to meet sales growth targets; risks relating to acquisitions, joint ventures, new venture investments and divestitures, and associated costs, including asset impairment charges related to, among others, intangible assets, trademarks and goodwill, integration costs and potential contingent liabilities related to those transactions; the company's ability to successfully execute or realize the anticipated benefits of its strategic or transformational initiatives, including its completed ERP implementation and post-implementation stabilization as well as the shift towards a simplified operating structure; the impact of the changing retail environment, including the growth of alternative retail channels and business models, the increasing use of artificial intelligence by discovery and retailer platforms, and changing consumer preferences; intense competition in the company's markets; volatility and increases in the costs of raw materials, energy, transportation, labor and other necessary supplies or services; risks related to supply chain issues, product shortages and disruptions to the business, as a result of increased supply chain dependencies due to an expanded supplier network and a reliance on certain single-source suppliers; risks related to the company's use of and reliance on information technology systems, including potential and actual security breaches, cyberattacks, privacy breaches or data breaches, including as a result of the increasing use of artificial intelligence by threat actors, that result in the unauthorized disclosure of consumer, customer, employee or company information, business, service or operational disruptions, or that impact the company's financial results or financial reporting, or any resulting unfavorable outcomes, increased costs or legal proceedings; the ability of the company to innovate, including to deliver product superiority across performance, value, packaging and brand experience, and to develop and introduce commercially successful products, or expand into adjacent categories and countries; the ability of the company to successfully manage global political, legal, tax and regulatory risks, including due to regulatory uncertainty and lack of regulatory convergence among different jurisdictions; lower revenue, increased costs, other financial statement impacts or reputational harm resulting from government actions, compliance with regulations, or any material costs imposed by changes in regulation; the company's ability to maintain its business reputation and the reputation of its brands and products; dependence on key customers and risks related to customer consolidation and ordering patterns; the company's ability to attract and retain key personnel, which may continue to be impacted by challenges in the labor market, such as increasing labor costs and sustained labor shortages, as well as the company's ability to manage leadership transitions, including the previously announced CEO succession, and retain and integrate key employees of acquired businesses; changes to the company's processes and procedures as a result of its digital capabilities and productivity enhancements, its increasing use of emerging technologies such as artificial intelligence, and the integration of acquired businesses (including Clorox Purell ProCare) that may result in changes to the company's internal controls over financial reporting; risks related to the company's continued operation of the Glad business; risks related to international operations and international trade, including changing macroeconomic conditions as a result of inflation, volatile commodity prices and increases in raw and packaging materials prices, labor, energy and logistics; global economic or political instability; foreign currency fluctuations, such as devaluations, and foreign currency exchange rate controls; changes in governmental policies, including trade policy and tariffs, travel or immigration restrictions, new or additional tariffs, and price or other controls; labor claims and civil unrest; potential operational or supply chain disruptions from wars and military conflicts, including active armed conflicts and military hostilities in the Middle East, such as the ongoing conflict involving Iran, and/or Ukraine and rising tensions in various parts of the world, such as between China and Taiwan; potential negative impact and liabilities from the use, storage and transportation of chlorine in certain international markets where chlorine is used in the production of bleach; widespread health emergencies; and the possibility of nationalization, expropriation of assets or other government action or inaction, including the impacts of any prolonged U.S. government shutdown; risk of reductions in the estimated fair value of the Burt's Bees trademark and potential impairment charges; the impact of climate change and other sustainability issues on sales, operating costs, reputation or stakeholder relationships; the impact of product liability claims, labor claims and other legal, governmental or tax proceedings, including in foreign jurisdictions and in connection with any product recalls; the accuracy of the company's estimates and assumptions on which its financial projections, including any sales or earnings guidance or outlook it may provide from time to time, are based; risks related to the company's reliance on third-party service providers, including inability to meet cost savings or efficiencies, business or systems disruptions, and other liabilities, including legal or regulatory risk; environmental matters, including costs associated with the remediation and monitoring of past contamination, and possible increases in costs resulting from actions by relevant regulators, and the handling and/or transportation of hazardous substances; the company's ability to effectively utilize, assert and defend its intellectual property rights, and any infringement or claimed infringement by the company of third-party intellectual property rights; the effect of the company's indebtedness and credit rating, including increased indebtedness resulting from the GOJO acquisition and Glad joint venture buyout, and the downgrade of the company's long-term credit ratings by S&P Global Ratings, on its business operations and financial results and the company's ability to access capital markets and other funding sources, as well as the cost of capital to the company; the company's ability to pay and declare dividends or repurchase its stock in the future; and the impacts of potential stockholder activism.

The company's forward-looking statements in this press release are based on management's current views, beliefs, assumptions and expectations regarding future events and speak only as of the date of this press release. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the federal securities laws.

Non-GAAP Financial Information

  • This press release contains non-GAAP financial information related to organic sales growth / (decrease), adjusted EPS, and segment adjusted EBIT for the first quarter of fiscal year 2027, as well as organic sales growth / (decrease) and adjusted EPS outlook for fiscal year 2027. The reasons management believes these measures are useful to investors are described below. Certain non-GAAP financial measures may be considered in determining incentive compensation.

  • Clorox defines organic sales growth / (decrease) as GAAP net sales growth / (decrease) excluding the effect of foreign exchange rate changes and any acquisitions or divestitures.

  • Management believes that the presentation of organic sales growth / (decrease) is useful to investors because it excludes sales from any acquisitions and divestitures, which results in a comparison of sales only from the businesses that the company was operating and expects to continue to operate throughout the relevant periods, and the company's estimate of the impact of foreign exchange rate changes, which are difficult to predict and out of the control of the company and management. However, organic sales growth / (decrease) may not be the same as similar measures provided by other companies due to potential differences in methods of calculation or differences in which items are incorporated into these adjustments.

  • Organic Sales, Adjusted Cost of Products Sold, Adjusted Gross Profit, Adjusted Gross Margin, Adjusted Selling and Administrative expenses, Adjusted Other (Income) Expense, Net, Adjusted Net Earnings Attributable to Clorox, and Adjusted Diluted Net Earnings Per Share are calculated in accordance with GAAP, that excludes or has otherwise been adjusted for significant items that are nonrecurring or unusual that are not indicative of the company's underlying operations. The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment. Non-GAAP measures may not be the same as similar measures provided by other companies due to potential differences in methods of calculation or differences in which items are incorporated into these adjustments.

  • Adjusted EBIT represents earnings (losses) before income taxes excluding interest income, interest expense and other significant items that are nonrecurring or unusual that are not indicative of the company's underlying operations. The company uses this measure to assess the operating results and performance of its segments, perform analytical comparisons, identify strategies to improve performance, and allocate resources to each segment. Adjusted EBIT may not be the same as similar measures provided by other companies due to potential differences in methods of calculation or differences in which items are incorporated into these adjustments.

  • The non-GAAP measures listed above are supplemental information that management uses to help evaluate the company's historical and prospective financial performance on a consistent basis over time. Management believes that by adjusting for certain items affecting comparability of performance over time, such as the pension settlement charge, incremental costs and insurance recoveries related to the August 2023 cyberattack, asset impairments, charges related to the digital capabilities and productivity enhancements investment, transaction and integration costs related to acquisitions, significant losses related to divestitures and other nonrecurring or unusual items, investors and management are able to gain additional insight into the company's underlying operating performance on a consistent basis over time.

  • The reconciliation tables below refer to the equivalent GAAP measures adjusted as applicable for the following items:

Acquisition and Integration Costs

On April 1, 2026, the company completed the previously announced acquisition of GOJO Industries. As a result of this transaction, various acquisition and integration-related costs were and will be incurred related to the acquisition and efforts to integrate the recently acquired business to the company's systems and processes. These costs include inventory step-up charges representing expense recognition of fair value adjustments in excess of the historical cost basis of inventory obtained through the acquisition, as well as direct acquisition transaction costs and legal-entity, operational, manufacturing, and information technology integration costs.

Due to the nature, scope and magnitude of these costs, the company's management believes presenting these costs as an adjustment in the non-GAAP results provides additional information to investors about trends in the company's operations and is useful for period over period comparisons. It also allows investors to view underlying operating results in the same manner as they are viewed by company management.

Digital Capabilities and Productivity Enhancements Investment

As announced in August 2021, the company invested in transformative technologies and processes over a five-year period beginning in fiscal year 2022 and completed during the third quarter of fiscal year 2026. The investment included replacement of the company's ERP system and transitioning to a cloud-based platform as well as the implementation of a suite of other digital technologies. The total incremental transformational investment was approximately $580 million. It is expected that these implementations will generate efficiencies and transform the company's operations in the areas of supply chain, digital commerce, innovation, brand building and more over the long term.

Of the total investment, approximately 75% represented incremental operating costs primarily recorded within selling and administrative expenses to be adjusted from reported EPS for purposes of disclosing adjusted EPS. About 70% of these operating costs were related to the implementation of the ERP, with the remaining costs primarily related to the implementation of complementary technologies.

Due to the nature, scope and magnitude of this investment, these costs were considered by management to represent incremental transformational costs above the historical normal level of spending for information technology to support operations. Since these strategic investments, including incremental operating costs, ceased at the end of the investment period, are not expected to recur in the foreseeable future and are not considered representative of the company's underlying operating performance, the company's management believes presenting these costs as an adjustment in the non-GAAP results provides additional information to investors about trends in the company's operations and is useful for period-over-period comparisons. It also allows investors to view underlying operating results in the same manner as they are viewed by company management.

The following table provides reconciliation of organic sales growth / (decrease) (non-GAAP) to net sales growth / (decrease), the most comparable GAAP measure:

Three months ended September 30, 2026
Percentage change versus the year-ago period
Health and Wellness Household Lifestyle International Total Company (1)
Net sales growth / (decrease) (GAAP) 62 % 17 % 16 % 11 % 33 %
Add: Foreign exchange — — — (2) —
Add/(Subtract): Divestitures/acquisitions(2) (39) — — — (15)
Organic sales growth / (decrease) (non-GAAP) 23 % 17 % 16 % 9 % 18 %
(1) Total Company includes Corporate and Other.
(2) Reflects the impact of the GOJO acquisition.

The following tables provide reconciliations of adjusted non-GAAP line items to the most comparable GAAP measure:

Reconciliation of Non-GAAP Measures
Three months ended September 30, 2026
As Reported GAAP Acquisition and integration costs Adjusted(non-GAAP)
Cost of products sold $           1,135 $                (10) $           1,125
Gross profit 770 10 780
Gross margin 40.4 % 40.9 %
Selling and administrative expenses 290 (16) 274
Percent of net sales 15.2 % 14.4 %
Other (income) expense, net 2 — 2
Net earnings attributable to Clorox 170 20 190
Diluted net earnings per share $             1.39 $               0.16 $             1.55

The following tables provide reconciliations of adjusted diluted earnings per share (non-GAAP) to diluted earnings per share, the most comparable GAAP measure:

Adjusted Diluted Earnings Per Share (EPS)
(Dollars in millions except per share data)
Diluted earnings per share
Three months ended
9/30/2026 9/30/2025 % Change
As reported (GAAP) $          1.39 $          0.65 114 %
Acquisition and integration costs(1) 0.16 —
Digital capabilities and productivity enhancements investment(2) — 0.20
As adjusted (non-GAAP) $          1.55 $          0.85 82 %
(1) During the three months ended September 30, 2026, the company incurred approximately $26 ($20 after tax) of costs related to the       GOJO acquisition.
(2) During the three months ended September 30, 2025, the company incurred approximately $32 ($25 after tax) of operating expenses      related to its digital capabilities and productivity enhancements investment.

The following table provides reconciliation of adjusted EBIT (non-GAAP) to earnings before income taxes, the most comparable GAAP measure:

Reconciliation of earnings before income taxes to adjusted EBIT
Three months ended
9/30/2026 9/30/2025
Earnings before income taxes $        207 $        107
Interest income (1) (2)
Interest expense 52 23
Acquisition and integration costs 26 —
Digital capabilities and productivity enhancements investment — 32
Adjusted EBIT $        284 $        160
Full year 2027 outlook (estimated range)
Diluted earnings per share
Low High
As estimated (GAAP) $          5.41 $          5.71
Acquisition and integration costs(1) 0.29 0.29
As adjusted (non-GAAP) $          5.70 $          6.00
(1) In fiscal year 2027, the company expects to incur approximately $46 ($35 after tax) of costs related to the GOJO acquisition.
Condensed Consolidated Statements of Earnings (Unaudited)
Dollars in millions, except per share data
Three months ended
9/30/2026 9/30/2025
Net sales $        1,905 $     1,429
Cost of products sold 1,135 833
Gross profit 770 596
Selling and administrative expenses 290 277
Advertising costs 190 166
Research and development costs 29 28
Interest expense 52 23
Other (income) expense, net 2 (5)
Earnings before income taxes 207 107
Income tax expense 34 25
Net earnings 173 82
Less: Net earnings attributable to noncontrolling interests 3 2
Net earnings attributable to Clorox $          170 $         80
Net earnings per share attributable to Clorox
Basic net earnings per share $          1.39 $       0.65
Diluted net earnings per share $          1.39 $       0.65
Weighted average shares outstanding (in thousands)
Basic 121,619 122,629
Diluted 122,027 123,018
Reportable Segment Information
(Unaudited)
Dollars in millions
Net sales
Three months ended
9/30/2026 9/30/2025 % Change**(1)**
Health and Wellness $       918 $       565 62 %
Household 423 362 17 %
Lifestyle 283 245 16 %
International 281 253 11 %
Reportable segment total 1,905 1,425
Corporate and Other — 4 (100) %
Total $     1,905 $     1,429 33 %
Segment adjusted EBIT
Three months ended
9/30/2026 9/30/2025 % Change**(1)**
Health and Wellness $       209 $       124 69 %
Household 30 27 11 %
Lifestyle 60 38 58 %
International 31 19 63 %
Reportable segment total 330 208
Corporate and Other (46) (48)
Interest income 1 2
Interest expense (52) (23)
Acquisition and integration costs(2) (26) —
Digital capabilities and productivity enhancements investment (3) — (32)
Earnings before income taxes $       207 $       107 93 %
(1) Percentages based on rounded numbers.
(2) Represents expenses related to the company's acquisition and integration of GOJO of $26 ($20 after tax) for the three months ended       September 30, 2026
(3) Represents expenses related to the company's digital capabilities and productivity enhancements investment of $32 ($25 after tax) for       the three months ended September 30, 2025.
Condensed Consolidated Balance Sheets
Dollars in millions
9/30/2026 6/30/2026 9/30/2025
(Unaudited) (Unaudited)
ASSETS
Current assets
Cash and cash equivalents $          184 $          143 $         166
Receivables, net 745 791 703
Inventories, net 774 777 577
Prepaid expenses and other current assets 228 113 249
Total current assets 1,931 1,824 1,695
Property, plant and equipment, net 1,482 1,512 1,251
Operating lease right-of-use assets 384 401 318
Goodwill 1,944 1,945 1,227
Trademarks, net 988 989 502
Other intangible assets, net 593 606 59
Other assets 510 517 476
Total assets $        7,832 $        7,794 $       5,528
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Notes and loans payable $        1,175 $        1,086 $         218
Current maturities of long-term debt 1 1 —
Current operating lease liabilities 89 86 89
Accounts payable and accrued liabilities 1,689 1,600 1,927
Total current liabilities 2,954 2,773 2,234
Long-term debt 3,982 3,981 2,485
Long-term operating lease liabilities 347 366 286
Other liabilities 412 405 365
Deferred income taxes 16 17 20
Total liabilities 7,711 7,542 5,390
Commitments and contingencies
Stockholders' equity
Preferred stock — — —
Common stock 131 131 131
Additional paid-in capital 1,320 1,312 1,326
Retained earnings 247 386 200
Treasury stock (1,579) (1,582) (1,514)
Accumulated other comprehensive net (loss) income (158) (157) (165)
Total Clorox stockholders' (deficit) equity (39) 90 (22)
Noncontrolling interests 160 162 160
Total stockholders' equity 121 252 138
Total liabilities and stockholders' equity $        7,832 $        7,794 $       5,528

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/clorox-reports-q1-fiscal-year-2027-results-updates-outlook-302926739.html

SOURCE The Clorox Company

View All News

Media Contacts

Business/financial media inquiries:

[email protected]

Brand media inquiries:

Click here to view individual brand contacts

Investor inquiries:

[email protected]

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At The Clorox Company, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to The Clorox Company to send you the requested Investor Email Alert updates.

* Required

Investor Alert OptionsEmail Address * Investor Alert Options *

News
Quarterly Reports
Annual Reports
SEC Filings
End of Day Stock Quote
Events & Presentations

Submit Sign Up

Unsubscribe

Email Alert Sign Up Confirmation



Accessibility Statement

The Clorox Company is committed to making its website accessible for all users, and will continue to take steps necessary to ensure compliance with applicable laws.

If you have difficulty accessing any content, feature or functionality on our website or on our other electronic platforms, please call us at 1-800-227-1860 so that we can provide you access through an alternative method.


© 2024 The Clorox Company. All Rights Reserved.

The Clorox Company Family of Brands

(Opens in new window)

Clorox Appoints Fabian Garcia as CEO Bull 2 Bear 0 Management

10/29/2026

Matthew Shattock to Resume Position as Independent Chair

OAKLAND, Calif., Oct. 29, 2026 /PRNewswire/ -- The Clorox Company (NYSE: CLX) today announced that its Board of Directors has appointed Fabian Garcia as CEO, effective Jan**.** 5, 2027, following a comprehensive search. Garcia will succeed Linda Rendle, who announced in May that she would step down for health reasons. Rendle will continue to serve as chair and CEO until Garcia assumes the CEO role.

At the time of Garcia's appointment, he will join the Board of Directors, and Matthew Shattock, the company's lead independent director and former Board chair, will become independent chair. On that date, Rendle will step down as CEO and as a director, while continuing to serve in an advisory capacity through April 2, 2027 to ensure a smooth transition.

"Fabian is an accomplished global business leader with an exceptional track record of delivering results, building enduring brands and developing high-performing teams," said Shattock. "His experience leading large-scale consumer businesses, advancing innovation, successfully managing complex and evolving customer and channel dynamics, and driving disciplined growth makes him well suited to lead Clorox. The Board is confident that Fabian has the vision and leadership to build on the strong foundation Linda has established, strengthen execution and position Clorox for sustainable value creation."

Shattock continued, "We are also incredibly grateful for Linda's leadership through some of the most consequential moments in the company's history. She strengthened the business and positioned it for the future. We greatly appreciate her continued support during this transition."

Garcia currently serves as president of Unilever Personal Care and is a member of the Unilever Leadership Executive team, bringing more than four decades of global consumer products leadership experience. Since joining Unilever in 2020, he has held several senior leadership roles, including serving as president of Unilever North America. Before joining Unilever, Garcia served as CEO of Revlon and as chief operating officer for Global Innovation and Growth at Colgate-Palmolive, where he led global growth strategy, consumer innovation and operational productivity initiatives. Earlier in his career, he held a series of global leadership roles at Procter & Gamble, helping shape his foundation in brand building, commercial excellence and consumer-focused growth. Garcia currently serves on the Board of Directors of Wells Fargo, having previously served on the boards of Kimberly-Clark and Arrow Electronics.

"I am honored to join Clorox and grateful for the Board's confidence," said Garcia. "This is a company with an exceptional portfolio of trusted brands, deep consumer loyalty, a clear purpose and a talented team. While there is more work ahead to strengthen performance and realize the company's full potential, I am energized by the opportunity and confident in Clorox's future. I look forward to working with the team to build on these strengths, drive growth and create long-term value for all of our stakeholders."

"It has been the privilege of my career to lead Clorox and work alongside such talented teammates around the world," said Rendle. "As I prepare to hand over leadership of this remarkable company in the coming months, I do so with great confidence. Clorox's future is bright, and I look forward to seeing all that the company will accomplish under Fabian's leadership."

Clorox will report its first-quarter fiscal year 2027 earnings results on Monday, Nov. 2, and Rendle and Chief Financial Officer Luc Bellet will participate in an earnings call with analysts. Links to the webcast, press release and prepared remarks can be found at Clorox Quarterly Results

Prompts

Clorox Company (The) (ticker CLX), listed in United States.

ETFs Holding Clorox Company (The)

ETF Weight in ETF Shares Market value As of
DIVY 1.91% 5,209 $ 573.876K Nov 17, 2026
CSTK 1.68% 31,020 $ 2.963M Jul 31, 2026
WCEO 1.35% 1,411 $ 134.793K Jul 31, 2026
DWSH short -0.93% -537 $ -57.298K Nov 17, 2026
SELV 0.48% 12,368 $ 1.18M Jun 30, 2026
PAPI 0.42% 17,664 $ 1.686M Jun 30, 2026
ITAN 0.36% 4,113 $ 438.857K Nov 17, 2026
AVIE 0.28% 421 $ 46.382K Nov 16, 2026
SHRT 0.25% 293 $ 32.28K Nov 17, 2026
GOP 0.23% 1,807 $ 199.077K Nov 17, 2026
DFAS 0.22% 671,597 $ 72.667M Nov 12, 2026
CAPE 0.19% 4,781 $ 456.299K Jun 30, 2026
INRO 0.19% 10,145 $ 1.118M Nov 16, 2026
LCTU 0.19% 19,037 $ 2.097M Nov 16, 2026
RAA 0.16% 9,995 $ 953.923K Jun 30, 2026
IALT short -0.13% -93,430 $ -10.293M Nov 16, 2026
AVMC 0.08% 3,988 $ 439.358K Nov 16, 2026
IEDI 0.04% 107 $ 10.222K Jul 31, 2026
XMAG 0.03% 554 $ 59.943K Nov 13, 2026
AVSU 0.03% 1,451 $ 159.857K Nov 16, 2026
DFAC 0.03% 235,552 $ 25.487M Nov 12, 2026
DXUV 0.03% 15,100 $ 1.634M Nov 12, 2026
DCOR 0.02% 89,658 $ 9.701M Nov 12, 2026
DFUS 0.02% 37,134 $ 4.018M Nov 12, 2026
VOXP 0.01% 9 $ 859.77 Jul 31, 2026
HCMT 0.01% 842 $ 80.436K Jul 31, 2026
CSHP 0.01% 249 $ 27.432K Nov 16, 2026
AVLC 0.01% 1,879 $ 207.009K Nov 16, 2026
GSPY 0.01% 449 $ 49.466K Nov 17, 2026
DFAU 0.01% 10,859 $ 1.175M Nov 12, 2026
ACVF 0.01% 107 $ 10.222K Jul 31, 2026
DFSU 0.00% 538 $ 58.212K Nov 12, 2026
EBI 0.00% 12 $ 1,172.16 Aug 31, 2026
AVUS 0.00% 117 $ 12.89K Nov 16, 2026
CORO 0.00% 76 $ 8,397.80 Nov 16, 2026